Your browser doesn't support javascript.
loading
Detectability of Target Lesion During CT-Guided Tumor Ablations: Impact on Ablation Outcome.
Barzakova, Emona; Senthilvel, Niveditha; Bruners, Philipp; Keil, Sebastian; Lurje, Georg; Zimmermann, Markus; Kuhl, Christiane K; Isfort, Peter.
Affiliation
  • Barzakova E; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Senthilvel N; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Bruners P; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Keil S; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Lurje G; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Germany.
  • Zimmermann M; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Kuhl CK; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
  • Isfort P; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany.
Rofo ; 194(5): 515-520, 2022 05.
Article in En | MEDLINE | ID: mdl-34794185
ABSTRACT

PURPOSE:

Small hepatic malignancies scheduled for CT-guided percutaneous ablation may have been identified in the hepatobiliary phase of liver MRI or in a specific phase of multi-phase CT but may be occult on unenhanced CT used to guide the ablation. We investigated whether the detectability of the target lesion would impact the efficacy of CT-guided hepatic tumor ablations. MATERIALS AND

METHODS:

We included 69 patients with 99 malignant liver lesions (25 primary, 44 metastases) who underwent IRE (n = 35), RFA (n = 41), or MWA (n = 23) between 01/2015 and 06/2018. All procedures were performed under CT guidance. Lesions not detectable on CT (NDL) were targeted through identification of anatomical landmarks on preinterventional contrast-enhanced CT or MRI. Rates of incomplete ablation, size of ablation zone, local tumor recurrence, intrahepatic progression-free survival (ihPFS), and adverse event rates were compared for detectable lesions (DL) vs. NDL.

RESULTS:

40 lesions were NDL, and 59 lesions were DL on unenhanced CT. The mean follow-up was 16.2 months (14.8 for DL and 18.2 for NDL). The mean diameter of NDL and DL was similar (12.9 mm vs. 14.9 mm). The mean ablation zone size was similar (37.1 mm vs. 38.8 mm). Incomplete ablation did not differ between NDL vs. DL (5.0 % [2/40; 0.6-16.9 %] vs. 3.4 % [2/59; 0.4-11.7 %]), nor did local tumor recurrence (15.4 % [6/39; 5.7 %-30.5 %] vs. 16.9 % [10/59; 8.4-29.0 %]), or median ihPFS (15.5 months vs. 14.3 months).

CONCLUSION:

Target lesion detectability on interventional CT does not have a significant impact on outcome after percutaneous liver ablation when anatomical landmarks are used to guide needle placement. KEY POINTS · Liver tumors can be successfully ablated even if they are not detectable on the navigational CT scan.. · Anatomical landmarks should be used and compared to preinterventional imaging.. CITATION FORMAT · Barzakova E, Senthilvel N, Bruners P et al. Detectability of Target Lesion During CT-Guided Tumor Ablations Impact on Ablation Outcome . Fortschr Röntgenstr 2022; 194 515 - 520.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Catheter Ablation / Liver Neoplasms Limits: Humans Language: En Journal: Rofo Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Catheter Ablation / Liver Neoplasms Limits: Humans Language: En Journal: Rofo Year: 2022 Document type: Article Affiliation country:
...